{"id":51452,"date":"2021-10-14T07:17:27","date_gmt":"2021-10-14T05:17:27","guid":{"rendered":"https:\/\/smarthealth.live\/?p=51452"},"modified":"2021-10-10T12:02:56","modified_gmt":"2021-10-10T10:02:56","slug":"51452","status":"publish","type":"post","link":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/","title":{"rendered":"Bisu l\u00e8ve 3,2 millions de dollars lors d'un premier tour de table r\u00e9ussi"},"content":{"rendered":"<p><strong>La startup Bisu, sp\u00e9cialis\u00e9e dans la sant\u00e9 et le bien-\u00eatre, a lev\u00e9 3,2 millions de dollars lors d'un premier tour de table. Ce dernier a \u00e9t\u00e9 men\u00e9 par l'investisseur sud-cor\u00e9en QUAD, sp\u00e9cialis\u00e9 dans les biotechnologies. Des entreprises telles que ASICS Ventures Corporation, 15th Rock Ventures, Pacifico Investments et SOSV ont \u00e9galement particip\u00e9 \u00e0 l'\u00e9v\u00e9nement d'investissement.<\/strong><\/p>\n<p>La soci\u00e9t\u00e9 bas\u00e9e \u00e0 Tokyo a finalement r\u00e9uni son capital initial. Cela repr\u00e9sente environ 3,2 millions de dollars qui seront utilis\u00e9s pour d\u00e9velopper un \u00ab laboratoire de sant\u00e9 \u00e0 domicile \u00bb portable. Appel\u00e9 Bisu Body Coach, l\u2019appareil est capable de prodiguer des conseils personnalis\u00e9s en mati\u00e8re de nutrition et de mode de vie gr\u00e2ce \u00e0 des tests d'urine et de salive. Il se compose d'un b\u00e2ton de test jetable dot\u00e9 de la technologie microfluidique qui peut en deux minutes vous pr\u00e9senter les r\u00e9sultats. Il est aussi \u00e9quip\u00e9 d'un lecteur, qui synchronise vos donn\u00e9es avec l'application sur votre smartphone.<\/p>\n<p>Une fois les r\u00e9sultats trait\u00e9s, l'application vous donne un retour sur les indicateurs nutritionnels cl\u00e9s tels que l'hydratation, les min\u00e9raux et les vitamines. L'appareil fournit \u00e9galement des recommandations personnalis\u00e9es en fonction des objectifs de l'utilisateur. Il s'agit notamment de vos pr\u00e9f\u00e9rences alimentaires, de votre activit\u00e9 physique, de votre sommeil et de votre poids.<\/p>\n<h3>Un march\u00e9 mondial<\/h3>\n<p>Bisu p\u00e9n\u00e8tre sur un march\u00e9 jusqu'ici domin\u00e9 par des acteurs proposant des solutions pour la COVID-19. Cette ann\u00e9e, MediCircle (une start-up sp\u00e9cialis\u00e9e dans la sant\u00e9 par l'IA) et DOC2US (un fournisseur malaisien de t\u00e9l\u00e9m\u00e9decine) ont lanc\u00e9 leurs propres kits de d\u00e9pistage rapide du coronavirus \u00e0 usage domestique. La soci\u00e9t\u00e9 ta\u00efwanaise iXensor et la soci\u00e9t\u00e9 indienne Inito figurent parmi les fournisseurs de solutions de fertilit\u00e9 \u00e0 distance en Asie. Fior Markets a pr\u00e9vu que le march\u00e9 mondial du diagnostic \u00e0 domicile passerait de 4,78 milliards de dollars en 2017 \u00e0 6,53 milliards de dollars en 2025.<\/p>\n<p>\u00ab <em>Ce financement est un important vote de confiance de la part d'un groupe d'investisseurs qui sont \u00e0 la fois f\u00e9rus de technologie, ax\u00e9s sur le consommateur et orient\u00e9s vers le monde.<\/em>\u00bb, a d\u00e9clar\u00e9 le cofondateur et PDG de Bisu, Daniel Maggs. Le pr\u00e9sident d\u2019ASICS Ventures, Hiroaki Kageyama, partage son avis. Il a d\u2019ailleurs affirm\u00e9 qu'ils \u00e9taient tr\u00e8s heureux d'investir dans Bisu en raison de son caract\u00e8re innovant. \u00ab <em>Nous pensons que sa technologie de laboratoire de sant\u00e9 \u00e0 domicile, qui permet un acc\u00e8s abordable \u00e0 des donn\u00e9es de sant\u00e9 exploitables, a un \u00e9norme potentiel.<\/em> \u00bb<\/p>\n<h3>Le comp\u00e9titeur am\u00e9ricain<\/h3>\n<p>La soci\u00e9t\u00e9 am\u00e9ricaine <a href=\"https:\/\/www.wsj.com\/articles\/BL-DGB-38929\">Cue<\/a> propose un service similaire \u00e0 celui de Bisu. Elle prend \u00e9galement certaines mesures \u00e0 partir d'\u00e9chantillons de sang, de salive ou de mucus nasal. Ce laboratoire \u00e0 domicile donne \u00e0 l'utilisateur diverses informations. En effet, il \u00e9value notamment :<\/p>\n<ul>\n<li>le taux de vitamine D,<\/li>\n<li>la fertilit\u00e9 (sur la base de l'hormone lut\u00e9inisante),<\/li>\n<li>la testost\u00e9rone, la grippe (grippe A)<\/li>\n<li>et l'inflammation (sur la base de la prot\u00e9ine C-r\u00e9active).<\/li>\n<\/ul>\n<p>Ces informations sont envoy\u00e9es par Bluetooth \u00e0 l'application dans laquelle les utilisateurs re\u00e7oivent des conseils adapt\u00e9s pour am\u00e9liorer leur sant\u00e9. La start-up se d\u00e9marque par son design attrayant. \u00c9pur\u00e9 et color\u00e9, le laboratoire portatif fait la taille d'un Rubik's cube. Quant aux cartouches aux couleurs gaies, elles ne sont pas plus grandes qu\u2019une bo\u00eete d'allumettes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 bas\u00e9e \u00e0 Tokyo a finalement r\u00e9uni son capital initial pour d\u00e9velopper un \u00ab laboratoire de sant\u00e9 \u00e0 domicile \u00bb portable. Appel\u00e9 Bisu Body [&hellip;]<\/p>\n","protected":false},"author":43,"featured_media":51377,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4650],"tags":[5286,5285,5287,4865,5282,5283,5284,4878,4874],"class_list":["post-51452","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-financement","tag-asics-ventures-corporation","tag-biotechnologies","tag-bisu-fr","tag-coronavirus-fr","tag-echantillons","tag-medicircle","tag-quad","tag-soins-a-distance","tag-soins-a-domicile"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.8 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Bisu l\u00e8ve 3,2 millions de dollars lors d&#039;un premier tour de table r\u00e9ussi - Smarthealth<\/title>\n<meta name=\"description\" content=\"Le capital servira \u00e0 d\u00e9velopper le \u00ab laboratoire de sant\u00e9 \u00e0 domicile \u00bb portable, Bisu Body Coach capable d&#039;analyser des \u00e9chantillons d&#039;urine et de salive.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bisu l\u00e8ve 3,2 millions de dollars lors d&#039;un premier tour de table r\u00e9ussi\" \/>\n<meta property=\"og:description\" content=\"Le capital servira \u00e0 d\u00e9velopper le \u00ab laboratoire de sant\u00e9 \u00e0 domicile \u00bb portable, Bisu Body Coach capable d&#039;analyser des \u00e9chantillons d&#039;urine et de salive.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/\" \/>\n<meta property=\"og:site_name\" content=\"Smarthealth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/smarthealthnl\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-14T05:17:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Bisu-platform-e1633629110747.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Glen van Muylem\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SmartHealthNL\" \/>\n<meta name=\"twitter:site\" content=\"@SmartHealthNL\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glen van Muylem\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/\"},\"author\":{\"name\":\"Glen van Muylem\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/person\\\/553fd527c116489ace56bf38bea32229\"},\"headline\":\"Bisu l\u00e8ve 3,2 millions de dollars lors d'un premier tour de table r\u00e9ussi\",\"datePublished\":\"2021-10-14T05:17:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/\"},\"wordCount\":610,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Bisu-platform-e1633629110747.jpg\",\"keywords\":[\"ASICS Ventures Corporation\",\"biotechnologies\",\"Bisu\",\"coronavirus\",\"\u00e9chantillons\",\"MediCircle\",\"QUAD\",\"soins \u00e0 distance\",\"soins \u00e0 domicile\"],\"articleSection\":[\"financement\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/\",\"name\":\"Bisu l\u00e8ve 3,2 millions de dollars lors d'un premier tour de table r\u00e9ussi - Smarthealth\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Bisu-platform-e1633629110747.jpg\",\"datePublished\":\"2021-10-14T05:17:27+00:00\",\"description\":\"Le capital servira \u00e0 d\u00e9velopper le \u00ab laboratoire de sant\u00e9 \u00e0 domicile \u00bb portable, Bisu Body Coach capable d'analyser des \u00e9chantillons d'urine et de salive.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/#primaryimage\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Bisu-platform-e1633629110747.jpg\",\"contentUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Bisu-platform-e1633629110747.jpg\",\"width\":600,\"height\":400,\"caption\":\"Bisu\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/14\\\/51452\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bisu l\u00e8ve 3,2 millions de dollars lors d'un premier tour de table r\u00e9ussi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/\",\"name\":\"Smarthealth\",\"description\":\"Het kennisplatform voor digital health\",\"publisher\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#organization\",\"name\":\"SmartHealth\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logofutura400PIXBREED.png\",\"contentUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logofutura400PIXBREED.png\",\"width\":400,\"height\":96,\"caption\":\"SmartHealth\"},\"image\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/smarthealthnl\\\/\",\"https:\\\/\\\/x.com\\\/SmartHealthNL\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/person\\\/553fd527c116489ace56bf38bea32229\",\"name\":\"Glen van Muylem\",\"description\":\"Glen Van Muylem is freelance journalist. Door zijn bachelor- en masteropleiding taal- en letterkunde aan de universiteit van Gent houden het Nederlands en Engels geen geheimen meer voor hem. Tijdens zijn master-na-masteropleiding journalistiek aan de KU Leuven leerde hij heldere teksten te schrijven over diverse onderwerpen: van muziek over politiek tot gezondheidszorg.\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/author\\\/glen-van-muylem\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bisu l\u00e8ve 3,2 millions de dollars lors d'un premier tour de table r\u00e9ussi - Smarthealth","description":"Le capital servira \u00e0 d\u00e9velopper le \u00ab laboratoire de sant\u00e9 \u00e0 domicile \u00bb portable, Bisu Body Coach capable d'analyser des \u00e9chantillons d'urine et de salive.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/","og_locale":"fr_FR","og_type":"article","og_title":"Bisu l\u00e8ve 3,2 millions de dollars lors d'un premier tour de table r\u00e9ussi","og_description":"Le capital servira \u00e0 d\u00e9velopper le \u00ab laboratoire de sant\u00e9 \u00e0 domicile \u00bb portable, Bisu Body Coach capable d'analyser des \u00e9chantillons d'urine et de salive.","og_url":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/","og_site_name":"Smarthealth","article_publisher":"https:\/\/www.facebook.com\/smarthealthnl\/","article_published_time":"2021-10-14T05:17:27+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Bisu-platform-e1633629110747.jpg","type":"image\/jpeg"}],"author":"Glen van Muylem","twitter_card":"summary_large_image","twitter_creator":"@SmartHealthNL","twitter_site":"@SmartHealthNL","twitter_misc":{"\u00c9crit par":"Glen van Muylem","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/#article","isPartOf":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/"},"author":{"name":"Glen van Muylem","@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/person\/553fd527c116489ace56bf38bea32229"},"headline":"Bisu l\u00e8ve 3,2 millions de dollars lors d'un premier tour de table r\u00e9ussi","datePublished":"2021-10-14T05:17:27+00:00","mainEntityOfPage":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/"},"wordCount":610,"commentCount":0,"publisher":{"@id":"https:\/\/smarthealth.live\/fr\/#organization"},"image":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/#primaryimage"},"thumbnailUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Bisu-platform-e1633629110747.jpg","keywords":["ASICS Ventures Corporation","biotechnologies","Bisu","coronavirus","\u00e9chantillons","MediCircle","QUAD","soins \u00e0 distance","soins \u00e0 domicile"],"articleSection":["financement"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/","url":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/","name":"Bisu l\u00e8ve 3,2 millions de dollars lors d'un premier tour de table r\u00e9ussi - Smarthealth","isPartOf":{"@id":"https:\/\/smarthealth.live\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/#primaryimage"},"image":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/#primaryimage"},"thumbnailUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Bisu-platform-e1633629110747.jpg","datePublished":"2021-10-14T05:17:27+00:00","description":"Le capital servira \u00e0 d\u00e9velopper le \u00ab laboratoire de sant\u00e9 \u00e0 domicile \u00bb portable, Bisu Body Coach capable d'analyser des \u00e9chantillons d'urine et de salive.","breadcrumb":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/#primaryimage","url":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Bisu-platform-e1633629110747.jpg","contentUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Bisu-platform-e1633629110747.jpg","width":600,"height":400,"caption":"Bisu"},{"@type":"BreadcrumbList","@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/14\/51452\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smarthealth.live\/fr\/"},{"@type":"ListItem","position":2,"name":"Bisu l\u00e8ve 3,2 millions de dollars lors d'un premier tour de table r\u00e9ussi"}]},{"@type":"WebSite","@id":"https:\/\/smarthealth.live\/fr\/#website","url":"https:\/\/smarthealth.live\/fr\/","name":"Smarthealth","description":"Het kennisplatform voor digital health","publisher":{"@id":"https:\/\/smarthealth.live\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smarthealth.live\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/smarthealth.live\/fr\/#organization","name":"SmartHealth","url":"https:\/\/smarthealth.live\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/smarthealth.live\/wp-content\/uploads\/2013\/07\/logofutura400PIXBREED.png","contentUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2013\/07\/logofutura400PIXBREED.png","width":400,"height":96,"caption":"SmartHealth"},"image":{"@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/smarthealthnl\/","https:\/\/x.com\/SmartHealthNL"]},{"@type":"Person","@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/person\/553fd527c116489ace56bf38bea32229","name":"Glen van Muylem","description":"Glen Van Muylem is freelance journalist. Door zijn bachelor- en masteropleiding taal- en letterkunde aan de universiteit van Gent houden het Nederlands en Engels geen geheimen meer voor hem. Tijdens zijn master-na-masteropleiding journalistiek aan de KU Leuven leerde hij heldere teksten te schrijven over diverse onderwerpen: van muziek over politiek tot gezondheidszorg.","url":"https:\/\/smarthealth.live\/fr\/author\/glen-van-muylem\/"}]}},"_links":{"self":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts\/51452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/comments?post=51452"}],"version-history":[{"count":6,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts\/51452\/revisions"}],"predecessor-version":[{"id":51454,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts\/51452\/revisions\/51454"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/media\/51377"}],"wp:attachment":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/media?parent=51452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/categories?post=51452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/tags?post=51452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}